Let out a 40% stake in the National University pharmacy gourd sold in what medicine?

In several private listed pharmacies merger and acquisition battle, China's state-owned pharmaceutical retail giant Guoda Pharmacy to join the merger camp, is expected to lead the pharmacy mergers and acquisitions to the depth. Not long ago, the listed company State Pharmaceuticals unanimously issued the "25th meeting of the 7th Board of Directors resolution announcement", said that the Board of Directors considered and adopted the "on the wholly-owned subsidiary of State Pharmaceutical Holdings State University Pharmacy Co., Ltd. to increase capital to introduce strategic investors", agreed to the wholly-owned subsidiary of State Pharmaceutical Holdings State University Pharmacy Co., Ltd. to increase the capital to introduce a strategic investor, after the capital increase, China National Pharmaceutical Co., Ltd. unanimously held 60% of the shares of The National University Pharmacy, the newly introduced strategic investors holding 40%.
is new to the initiative of the University pharmacy to give up its 40 per cent stake. What is the deep-seated impact it will have on the National University pharmacy? What does it mean for the pharmaceutical retail industry as a whole, and what are the forward-looking guidance?is a strategic investor,
in recent years, China's pharmaceutical retail enterprises to introduce strategic investors are not in the minority. So what are strategic investors?
Strategic Investor is a legal person who meets the requirements of national laws and regulations, has cooperative relations or cooperation intention and potential with the issuer, and is willing to sign a strategic investment allocation agreement with the issuer in accordance with the requirements of the issuer's allocation, and is a legal person who has close business ties with the issuing company and wants to hold the shares of the issuing company for a long time. Corresponding to strategic investors, there are financial investors, venture investors and social individual investors and so on.
Unlike other investors, strategic investors often have the advantages of capital, technology, management, market, channels, talents, brands, etc., and can help or play an important role in regulating corporate governance and production management, improving innovation ability, enhancing core competitiveness, expanding product market share, and promoting industrial structure upgrading.
Because strategic investors are mostly powerful large enterprises, large groups or large investment institutions, coupled with the pursuit of long-term (generally holding more than 5 to 7 years) cooperation, strategic cooperation, naturally for the object of investment. Being able to hold hands with heavyweight strategic investors for deep-seated cooperation has become a symbol of the strength of the investment target.In the introduction of strategic investors behind
we must see the National University pharmacy this large-scale introduction of strategic investors of the state-owned enterprises mixed background, as well as the actual control of the National University pharmacy since the beginning of the introduction of private factors, to achieve institutional mechanism innovation and thus a flying development experience and historical origin.
the commercial circulation of drugs is the earliest deregulation field in China. Since the 1990s, China's pharmaceutical circulation system has under changed significantly, the national drug transfer business engaged in by the National Pharmaceutical Group has been cancelled, pharmaceutical companies have been decentralized or reformed, the National Pharmaceutical Group has almost become a "shell". It is under the pressure of this dilemma and breakthrough that China National Pharmaceutical Group vigorously carried out reform and restructuring, introduced private enterprises, multinational companies and other strategic investors, especially in January 2003 with Fosun Pharma, the establishment of China National Pharmaceutical Holdings, in the decision-making mechanism, market awareness, management methods, incentive mechanisms, etc. ahead of traditional state-owned enterprises Great stoevers, enterprises have always maintained a rapid and stable pace of development, from the beginning of 2003 to the listing of 2009, China Pharmaceutical Holdings operating income from 8.1 billion yuan to 47.1 billion yuan, quickly leapt to the top of the domestic pharmaceutical circulation and to this day.
Because of the dual role of state-owned capital and the institutional mechanism of private enterprises, State Pharmaceutical Group became one of the two pilot state-owned enterprises in 2014 led by SASAC to develop a mixed ownership economy;Companies and industry impact can be expected
not to underestimate the initiative of the National University pharmacy to introduce external strategic investors, should not underestimate the possible changes that this initiative may bring, its impact on the National University pharmacy, the impact on the pharmaceutical retailing industry may be far-reaching.
for the National University pharmacy, the benefits are multiple.
First of all, according to the size of the National University pharmacy, assets and other mass, 40% of the shares will be a significant number, the introduction of strategic investors at the same time bring pharmacy development, mergers and acquisitions and other much-needed large amounts of money, with sufficient cash flow and further improve the assets and operating conditions of the National University pharmacy.
second, it is possible to bring deep-seated changes in institutional mechanism, development vitality, growth potential, sales channels, talent and management to the Pharmacy of the National University.
, in the new store layout, regional integration and even mergers and acquisitions and restructuring, the National University pharmacy will come up with a big move, which will inevitably affect the industry's competitive landscape and ecological balance.
is grafting private factors in the mechanism system, enterprises revitalised and dynamic, but also have enough motivation to do what they want to do. In its 2016 annual report, China National Pharmaceutical Co., D.A., said that "in 2017, we should accelerate the pace of mergers and acquisitions of the University of China pharmacies, improve the social network layout of retail medical and therapeutic services, and promote the process of internationalization in a timely manner", which is clearly pointed out.
5 through the marriage of industry outreach, to seek and enrich the differentiated business model, can avoid the domestic retail chain fierce homogenization competition, and learn from the strategic investors' advanced management concepts, methods, technologies, tools, etc. to make up for their own short board, improve the level of operation management and profitability.
impact of this on the drug retailing industry remains to be seen. On the plus side, this provides a good model for the domestic pharmacy chain to liven up and develop, and opens up new ideas for the development of other pharmacies. What is uncertain is what major changes will be made in the development strategy and development path after the introduction of strategic investors, what big moves will be made in opening new stores, mergers and acquisitions, spin-off and listing, and how the four privately listed pharmacies and other peer pharmacies will respond to or respond to these changes.
In short, the introduction of strategic investors this trick instment of the National University pharmacy, help the National University pharmacy "short board complement, long board longer", but also in the industry left a "boulder", affecting or forcing other chain giants to come up with corresponding measures to keep up with the pace of development. the future to the four guesses
the central enterprise mixed reform is a big project, as a mixed reform pilot of the National Pharmaceutical Group is more high hopes. The mixed reform mode of China Pharmaceutical Group mainly includes the introduction of strategic investors, the implementation of equity incentives, the acquisition of holding private enterprises and so on. At present, the four future listing platform framework has been identified. National Pharmaceuticals shares, National Pharmaceuticals is the first pilot units of The National Pharmaceutical Group and National Pharmaceutical Holdings to develop a mixed ownership economy. It can be assured that the State Pharmaceutical Group in the subsidiary mix-up layout grand, long-term planning, in the National University pharmacy mixed reform when the introduction of strategic investors is only the first step.
due to substantive progress, information disclosure and other reasons, the outside world to the introduction of strategic investors in the National University pharmacy is not much known, there are many fogs or questions need to be clarified or waiting for the water to fall out. At present may wish to make the following bold guess:
first is which company or institution has the strength to become a strategic investor in the National University pharmacy?
coveting the National University pharmacy this fat meat is not in the minority, but whoever it is, must be in the industry and beyond have considerable strength of the industrial town. According to sasac mixed reform requirements and the consistent practice of national medicine, it can be confirmed that the enterprise is the strength of private enterprises or private capital.
second is how much real money will this mysterious strategic investor shell out to take a 40% stake in the national university pharmacy?
, according to the 2016 annual report, the retail business of the University of China Pharmacy achieved operating income of 9.11 billion yuan and net profit of 223 million yuan. According to the Evaluation Report of the Strategic Investor Project to be Introduced by Guoda Pharmacy Co., Ltd., as of the assessment of all assets and liabilities included in the assessment scope of the benchmark National University Pharmacy, the book value of total assets was 2.30,490.58 million yuan, the book value of liabilities was 1.211,180.75 million yuan, and the book value of net assets was 109,309.83 million yuan. The transfer price of 40% equity will be based on the asset assessment report. This price is not a small number, given the valuation or premium of similar companies in the industry.
is the strategic investors will come up with what substantive action to support or promote the development of the National University pharmacy?
action of the strategic investor side, pending further development of the event, strategic investors to remove the veil after clear. China National Pharmaceuticals unanimously this side also intends to increase the capital of its subsidiaries, pharmacy acquisition, its announcement is clear, the State University pharmacy under the company "Inner Mongolia National Congress" will be 28.35 million yuan to buy Hohhot City Tiantian-chi Pharmaceutical Chain Co., Ltd. 16 stores related assets and business, and to the Inner Mongolia National University capital increase of 29.01 million yuan.
Fourth is the strategic cooperation between the National Pharmaceutical Co., Ltd. Pharmacy and the new strategic investors, can it be as close and fruitful as the cooperation between the State Pharmaceutical Group and Fosun Pharma in the Holding of National Pharmaceuticals?
depends on the joint efforts of all parties. Based on the successful experience of The Pharmaceutical Group in this regard, drug retailing is a fully competitive field, with great demand and operating space for future mergers and acquisitions, asset consolidation, capital expansion, etc., and deep cooperation and success are high probability events. (21st Century Pharmacy)